Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy.

ABSTRACT:

Background

The prevalence of kidney involvement during SARS-CoV-2 infection has been reported to be high. Nevertheless, data are lacking about the determinants of acute kidney injury (AKI) and the combined effect of chronic kidney disease (CKD) and AKI in COVID-19 patients.

Methods

We collected data on patient demographics, comorbidities, chronic medications, vital signs, baseline laboratory test results and in-hospital treatment in patients with COVID-19 consecutively admitted to our Institution. Chronic kidney disease was defined as eGFR < 60 mL/min per 1.73 m² or proteinuria at urinalysis within 180 days prior to hospital admission. AKI was defined according to KDIGO criteria. The primary and secondary outcomes were the development of AKI and death.

Results<

SUBMITTER: Russo E 

PROVIDER: S-EPMC7538179 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature